CSL787

BIOLOGICAL2 trials

Sponsors

CSL Behring

Conditions

Non-cystic Fibrosis BronchiectasisNoncystic Fibrosis Bronchiectasis (NCFB)

Phase 1

Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)

CompletedNCT04643587

CSL BehringNoncystic Fibrosis Bronchiectasis (NCFB)

Start: 2020-12-07End: 2023-03-12Updated: 2023-12-15

Phase 2

Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

RecruitingNCT07048262

CSL BehringNon-cystic Fibrosis Bronchiectasis

Start: 2025-09-03End: 2028-03-28Target: 450Updated: 2025-11-07